Literature DB >> 12817026

Bcl6 is a transcriptional repressor for the IL-18 gene.

Nobue Takeda1, Masafumi Arima, Nobuhide Tsuruoka, Seiji Okada, Masahiko Hatano, Akemi Sakamoto, Yoichi Kohno, Takeshi Tokuhisa.   

Abstract

Bcl6 functions as a sequence-specific transcriptional repressor, and Bcl6-deficient (Bcl6(-/-)) mice have been reported to display Th2-type inflammatory diseases in multiple organs. Since IL-18 is a potent stimulator of Th2 cells, we examined the expression of IL-18 mRNA in bone marrow-derived macrophages from Bcl6(-/-) mice after LPS stimulation. Here we show that the expression was strikingly up-regulated after stimulation. The expression was also up-regulated in RAW264 cells, a murine macrophage cell line, by transfection with the dominant negative type of Bcl6 gene. We identified a putative Bcl6-binding DNA sequence (IL-18BS) upstream of exon 1 of the murine IL-18 gene and three IL-18BSs in the promoter region of human IL-18 gene. Binding of Bcl6 in nuclear protein from resting RAW264 cells to murine IL-18BS was detected by gel retardation assay and chromatin immunoprecipitation assay. The binding activity was diminished gradually in RAW264 cells after LPS stimulation. However, the amount of Bcl6 protein in these cells was constant over the period examined, suggesting the functional modification of Bcl6 protein after stimulation. Furthermore, murine IL-18BS was required for Bcl6 to repress the expression of the luciferase reporter gene under control of the IL-18 promoter. Taken together, Bcl6 is a key regulator of IL-18 production by macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817026     DOI: 10.4049/jimmunol.171.1.426

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma.

Authors:  J Iqbal; T C Greiner; K Patel; B J Dave; L Smith; J Ji; G Wright; W G Sanger; D L Pickering; S Jain; D E Horsman; Y Shen; K Fu; D D Weisenburger; C P Hans; E Campo; R D Gascoyne; A Rosenwald; E S Jaffe; J Delabie; L Rimsza; G Ott; H K Müller-Hermelink; J M Connors; J M Vose; T McKeithan; L M Staudt; W C Chan
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

2.  Endometrial BCL6 testing for the prediction of in vitro fertilization outcomes: a cohort study.

Authors:  Laura D Almquist; Creighton E Likes; Benjamin Stone; Kaitlin R Brown; Ricardo Savaris; David A Forstein; Paul B Miller; Bruce A Lessey
Journal:  Fertil Steril       Date:  2017-11-07       Impact factor: 7.329

3.  BCL6 controls neurogenesis through Sirt1-dependent epigenetic repression of selective Notch targets.

Authors:  Luca Tiberi; Jelle van den Ameele; Jordane Dimidschstein; Julie Piccirilli; David Gall; Adèle Herpoel; Angéline Bilheu; Jerome Bonnefont; Michelina Iacovino; Michael Kyba; Tristan Bouschet; Pierre Vanderhaeghen
Journal:  Nat Neurosci       Date:  2012-11-18       Impact factor: 24.884

4.  Switching to BCL-6 Negativity in Relapsed Diffuse Large B Cell Lymphoma Correlated with More Aggressive Disease Course.

Authors:  Milena Todorović; Bela Balint; Bosko Andjelic; Ziv Radisavljevic; Biljana Mihaljevic
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-02       Impact factor: 0.900

5.  Modulation of inflammatory gene expression by the ribotoxin deoxynivalenol involves coordinate regulation of the transcriptome and translatome.

Authors:  Kaiyu He; Xiao Pan; Hui-Ren Zhou; James J Pestka
Journal:  Toxicol Sci       Date:  2012-09-11       Impact factor: 4.849

6.  ADAR1 protein induces adenosine-targeted DNA mutations in senescent Bcl6 gene-deficient cells.

Authors:  Nobuhide Tsuruoka; Masafumi Arima; Nobuya Yoshida; Seiji Okada; Akemi Sakamoto; Masahiko Hatano; Hisae Satake; Eggi Arguni; Ji-Yang Wang; Jing-Hua Yang; Kazuko Nishikura; Souei Sekiya; Makio Shozu; Takeshi Tokuhisa
Journal:  J Biol Chem       Date:  2012-12-03       Impact factor: 5.157

7.  Hypoxia-induced IL-18 increases hypoxia-inducible factor-1alpha expression through a Rac1-dependent NF-kappaB pathway.

Authors:  Jeongki Kim; Yan Shao; Sang Yong Kim; Seyl Kim; Hyun Keun Song; Jun Ho Jeon; Hyun Woo Suh; Jin Woong Chung; Suk Ran Yoon; Young Sang Kim; Inpyo Choi
Journal:  Mol Biol Cell       Date:  2007-11-14       Impact factor: 4.138

8.  A data integration framework for prediction of transcription factor targets.

Authors:  Matti Nykter; Harri Lähdesmäki; Alistair Rust; Vesteinn Thorsson; Ilya Shmulevich
Journal:  Ann N Y Acad Sci       Date:  2009-03       Impact factor: 5.691

9.  Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.

Authors:  Lucas Ravaux; Chantal Denoyelle; Claire Monne; Isabelle Limon; Michel Raymondjean; Khadija El Hadri
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

Review 10.  Regulation of hematopoietic development by ZBTB transcription factors.

Authors:  Takahiro Maeda
Journal:  Int J Hematol       Date:  2016-06-01       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.